Neumora Therapeutics
NMRA
#8240
Rank
$0.31 B
Marketcap
$1.68
Share price
1.82%
Change (1 day)
30.23%
Change (1 year)

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for Neumora Therapeutics CIK: 0001885522

Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2026

10-Q Quarterly Report FY2026 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2023

10-Q Quarterly Report FY2023 Q3

Language: English

Quarterly Reports (10-Q)